These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1252753)

  • 21. Minimal residual disease in breast cancer: can it be used as a prognostic marker?
    Liakakos T
    Ann Surg Oncol; 2008 Jun; 15(6):1793-4. PubMed ID: 18239971
    [No Abstract]   [Full Text] [Related]  

  • 22. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
    Chen Z; Lu X; Huang R
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy for the detection of metastases.
    Krag D
    Cancer J; 2000 Apr; 6 Suppl 2():S121-4. PubMed ID: 10803825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis.
    Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
    Oncol Rep; 2004 Aug; 12(2):303-6. PubMed ID: 15254693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer of the breast in young women.
    Molnár L; Besznyák I; Köves I
    Acta Chir Hung; 1995-1996; 35(1-2):5-11. PubMed ID: 8659239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the metastasis of breast cancer to lymph nodes. II. Diagnosis of metastasis to internal mammary nodes using radiocolloid.
    Matsuo S
    Acta Med Okayama; 1974 Oct; 28(5):361-71. PubMed ID: 4281997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
    Zhao TT; Li JG; Li YM
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of the sentinel lymph nodes status in breast carcinoma using microscopic, immunohistochemical and cytomorphometric methods in order to establish new stadializations and therapeutic schemes.
    Stolnicu S; Coros MF; Podeanu DM; Carata E; Mezei T; Muscă S; Podoleanu C; Rădulescu D
    Rom J Morphol Embryol; 2009; 50(1):51-60. PubMed ID: 19221645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regional lymph nodes and mortality in breast cancer].
    Spirina NV; Ivinskaia NV
    Sov Med; 1989; (4):123. PubMed ID: 2788307
    [No Abstract]   [Full Text] [Related]  

  • 31. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation of tumor size, lymph node status and prognosis in breast cancer].
    Shen ZZ
    Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
    Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer.
    Mustonen P; Farin P; Kosunen O
    Ann Chir Gynaecol; 1990; 79(1):15-8. PubMed ID: 2192685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
    Crabb SJ; Bajdik CD; Leung S; Speers CH; Kennecke H; Huntsman DG; Gelmon KA
    Breast Cancer Res; 2008; 10(1):R6. PubMed ID: 18194560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paranodal tumour in breast cancer: extranodal extension versus vascular spread.
    Hartveit F
    J Pathol; 1984 Dec; 144(4):253-6. PubMed ID: 6520648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging work-up for stage I breast carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    Bassett L; Mendelson E; Böhm-Vélez M; Cardenosa G; D'Orsi C; Evans WP; Monsees B; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():955-9. PubMed ID: 11037522
    [No Abstract]   [Full Text] [Related]  

  • 40. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.